Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner.

Andriani F, Majorini MT, Mano M, Landoni E, Miceli R, Facchinetti F, Mensah M, Fontanella E, Dugo M, Giacca M, Pastorino U, Sozzi G, Delia D, Roz L, Lecis D.

J Hematol Oncol. 2018 Mar 20;11(1):45. doi: 10.1186/s13045-018-0594-4.

2.

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.

Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Morano F, Fucà G, Nikolinakos P, Drilon A, Hechtman JF, Christiansen J, Gowen K, Frampton GM, Gasparini P, Rossini D, Gigliotti C, Kim ST, Prisciandaro M, Hodgson J, Zaniboni A, Chiu VK, Milione M, Patel R, Miller V, Bardelli A, Novara L, Wang L, Pupa S, Sozzi G, Ross J, Di Bartolomeo M, Bertotti A, Ali S, Trusolino L, Falcone A, de Braud F, Cremolini C.

Ann Oncol. 2018 Mar 10. doi: 10.1093/annonc/mdy090. [Epub ahead of print]

PMID:
29538669
3.

Laparoscopic Neuronavigation for Deep Lateral Pelvic Endometriosis: Clinical and Surgical Implications.

Chiantera V, Petrillo M, Abesadze E, Sozzi G, Dessole M, Catello Di Donna M, Scambia G, Sehouli J, Mechsner S.

J Minim Invasive Gynecol. 2018 Mar 2. pii: S1553-4650(18)30145-6. doi: 10.1016/j.jmig.2018.02.015. [Epub ahead of print]

PMID:
29501810
4.

Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study.

Sozzi G, Uccella S, Berretta R, Petrillo M, Fanfani F, Monterossi G, Ghizzoni V, Frusca T, Ghezzi F, Chiantera V, Scambia G.

Int J Gynecol Cancer. 2018 May;28(4):684-691. doi: 10.1097/IGC.0000000000001223.

PMID:
29489475
5.

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2018 Feb 27;8(1):3965. doi: 10.1038/s41598-018-21279-z.

6.

Complement C4d-specific antibodies for the diagnosis of lung cancer.

Ajona D, Okrój M, Pajares MJ, Agorreta J, Lozano MD, Zulueta JJ, Verri C, Roz L, Sozzi G, Pastorino U, Massion PP, Montuenga LM, Blom AM, Pio R.

Oncotarget. 2017 Dec 26;9(5):6346-6355. doi: 10.18632/oncotarget.23690. eCollection 2018 Jan 19.

7.

Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer.

Berretta R, Capozzi VA, Sozzi G, Volpi L, Ceni V, Melpignano M, Giordano G, Marchesi F, Monica M, Di Serio M, Riccò M, Ceccaroni M.

Arch Gynecol Obstet. 2018 Apr;297(4):997-1004. doi: 10.1007/s00404-018-4675-y. Epub 2018 Jan 27.

PMID:
29380107
8.

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.

Mensah M, Borzi C, Verri C, Suatoni P, Conte D, Pastorino U, Orazio F, Sozzi G, Boeri M.

J Vis Exp. 2017 Oct 26;(128). doi: 10.3791/56326.

9.

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2017 Jul 27;7(1):6689. doi: 10.1038/s41598-017-06912-7. Erratum in: Sci Rep. 2018 Feb 27;8(1):3965.

10.

Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study.

Lucidi A, Windemut S, Petrillo M, Dessole M, Sozzi G, Vercellino GF, Baessler K, Vizzielli G, Sehouli J, Scambia G, Chiantera V.

Int J Gynecol Cancer. 2017 Sep;27(7):1501-1507. doi: 10.1097/IGC.0000000000001045.

PMID:
28708791
11.

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.

Pastorino U, Morelli D, Leuzzi G, Gisabella M, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G.

Eur J Cancer. 2017 Jul;79:90-97. doi: 10.1016/j.ejca.2017.03.020. Epub 2017 May 1.

12.

Detection of microRNAs Using Chip-Based QuantStudio 3D Digital PCR.

Borzi C, Calzolari L, Conte D, Sozzi G, Fortunato O.

Methods Mol Biol. 2017;1580:239-247. doi: 10.1007/978-1-4939-6866-4_16.

PMID:
28439837
13.

Inflammatory status and lung function predict mortality in lung cancer screening participants.

Pastorino U, Morelli D, Marchianò A, Sestini S, Suatoni P, Taverna F, Boeri M, Sozzi G, Cantarutti A, Corrao G.

Eur J Cancer Prev. 2017 Mar 23. doi: 10.1097/CEJ.0000000000000342. [Epub ahead of print]

PMID:
28333763
14.

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

Pereira C, Gimenez-Xavier P, Pros E, Pajares MJ, Moro M, Gomez A, Navarro A, Condom E, Moran S, Gomez-Lopez G, Graña O, Rubio-Camarillo M, Martinez-Martí A, Yokota J, Carretero J, Galbis JM, Nadal E, Pisano D, Sozzi G, Felip E, Montuenga LM, Roz L, Villanueva A, Sanchez-Cespedes M.

Clin Cancer Res. 2017 Jun 15;23(12):3203-3213. doi: 10.1158/1078-0432.CCR-16-1946. Epub 2017 Mar 16.

PMID:
28302866
15.

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.

Verri C, Borzi C, Holscher T, Dugo M, Devecchi A, Drake K, Sestini S, Suatoni P, Romeo E, Sozzi G, Pastorino U, Boeri M.

J Thorac Oncol. 2017 Jun;12(6):922-931. doi: 10.1016/j.jtho.2017.03.001. Epub 2017 Mar 14.

16.

mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.

Borzi C, Calzolari L, Centonze G, Milione M, Sozzi G, Fortunato O.

Int J Mol Sci. 2017 Jan 23;18(1). pii: E222. doi: 10.3390/ijms18010222.

17.

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab.

Bonanno L, De Paoli A, Zulato E, Esposito G, Calabrese F, Favaretto A, Santo A, Conte AD, Chilosi M, Oniga F, Sozzi G, Moro M, Ciccarese F, Nardo G, Bertorelle R, Candiotto C, De Salvo GL, Amadori A, Conte P, Indraccolo S.

Clin Cancer Res. 2017 Jul 1;23(13):3316-3324. doi: 10.1158/1078-0432.CCR-16-2410. Epub 2017 Jan 24.

PMID:
28119362
18.

Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg.

Redaelli V, Rossi G, Maderna E, Kovacs GG, Piccoli E, Caroppo P, Cacciatore F, Spinello S, Grisoli M, Sozzi G, Salmaggi A, Tagliavini F, Giaccone G.

Brain Pathol. 2018 Jan;28(1):72-76. doi: 10.1111/bpa.12480. Epub 2017 Feb 15.

PMID:
27997711
19.

Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non-Small Cell Lung Cancer.

Tassi E, Grazia G, Vegetti C, Bersani I, Bertolini G, Molla A, Baldassari P, Andriani F, Roz L, Sozzi G, Pastorino U, Mortarini R, Anichini A.

Cancer Res. 2017 Feb 15;77(4):851-861. doi: 10.1158/0008-5472.CAN-16-1387. Epub 2016 Dec 15.

20.

Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.

Valtorta S, Moro M, Prisinzano G, Bertolini G, Tortoreto M, Raccagni I, Pastorino U, Roz L, Sozzi G, Moresco RM.

J Nucl Med. 2017 Jan;58(1):42-47. doi: 10.2967/jnumed.116.176404. Epub 2016 Oct 20.

21.

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.

Turdo F, Bianchi F, Gasparini P, Sandri M, Sasso M, De Cecco L, Forte L, Casalini P, Aiello P, Sfondrini L, Agresti R, Carcangiu ML, Plantamura I, Sozzi G, Tagliabue E, Campiglio M.

Oncotarget. 2016 Oct 25;7(43):69649-69665. doi: 10.18632/oncotarget.11935.

22.

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature.

Fortunato O, Verri C, Pastorino U, Sozzi G, Boeri M.

Microarrays (Basel). 2016 Jul 5;5(3). pii: E18. doi: 10.3390/microarrays5030018.

23.

Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.

Gasparini P, Casanova M, Villa R, Collini P, Alaggio R, Zin A, Bonvini P, Antonescu CR, Boldrini R, Caserini R, Moro M, Centonze G, Meazza C, Massimino M, Bergamaschi L, Luksch R, Chiaravalli S, Bisogno G, Zaffaroni N, Daidone MG, Sozzi G, Ferrari A.

Oncotarget. 2016 Sep 13;7(37):58903-58914. doi: 10.18632/oncotarget.10368.

24.

Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome.

Berretta R, Marchesi F, Volpi L, Ricotta G, Monica M, Sozzi G, Di Serio M, Mautone D.

Taiwan J Obstet Gynecol. 2016 Jun;55(3):346-50. doi: 10.1016/j.tjog.2016.04.010.

25.

Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials.

Infante M, Sestini S, Galeone C, Marchianò A, Lutman FR, Angeli E, Calareso G, Pelosi G, Sozzi G, Silva M, Sverzellati N, Cavuto S, La Vecchia C, Santoro A, Alloisio M, Pastorino U.

Eur J Cancer Prev. 2017 Jul;26(4):324-329. doi: 10.1097/CEJ.0000000000000264.

PMID:
27222939
26.

Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes.

Morena D, Maestro N, Bersani F, Forni PE, Lingua MF, Foglizzo V, Šćepanović P, Miretti S, Morotti A, Shern JF, Khan J, Ala U, Provero P, Sala V, Crepaldi T, Gasparini P, Casanova M, Ferrari A, Sozzi G, Chiarle R, Ponzetto C, Taulli R.

Elife. 2016 Mar 17;5. pii: e12116. doi: 10.7554/eLife.12116.

27.

[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].

Sestini S, Boeri M, Marchianò A, Silva M, Calareso G, Galeone C, Sozzi G, Pastorino U.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 1):42-50. doi: 10.19191/EP16.1S1.P042.029. Italian.

28.

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.

Pastorino U, Boffi R, Marchianò A, Sestini S, Munarini E, Calareso G, Boeri M, Pelosi G, Sozzi G, Silva M, Sverzellati N, Galeone C, La Vecchia C, Ghirardi A, Corrao G.

J Thorac Oncol. 2016 May;11(5):693-9. doi: 10.1016/j.jtho.2016.02.011. Epub 2016 Feb 24.

29.

Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen.

Sverzellati N, Silva M, Calareso G, Galeone C, Marchianò A, Sestini S, Sozzi G, Pastorino U.

Eur Radiol. 2016 Nov;26(11):3821-3829. Epub 2016 Feb 11.

PMID:
26868497
30.

Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer.

Silva M, Galeone C, Sverzellati N, Marchianò A, Calareso G, Sestini S, La Vecchia C, Sozzi G, Pelosi G, Pastorino U.

J Thorac Oncol. 2016 Feb;11(2):187-93. doi: 10.1016/j.jtho.2015.10.014. Epub 2015 Dec 23.

31.

Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.

Pelosi G, Gasparini P, Conte D, Fabbri A, Perrone F, Tamborini E, Pupa SM, Ciravolo V, Caserini R, Rossi G, Cavazza A, Papotti M, Nakatani Y, Maisonneuve P, Pastorino U, Sozzi G.

J Thorac Oncol. 2016 May;11(5):718-28. doi: 10.1016/j.jtho.2016.01.009. Epub 2016 Jan 22.

32.

IL12RB2 Polymorphisms correlate with risk of lung adenocarcinoma.

Prigione I, Covone AE, Giacopelli F, Bocca P, Risso M, Tripodi G, Pistorio A, Sozzi G, Airoldi I, Ravazzolo R, Pistoia V.

Immunobiology. 2016 Feb;221(2):291-9. doi: 10.1016/j.imbio.2015.10.006. Epub 2015 Oct 29.

PMID:
26547104
33.

Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.

Andriani F, Bertolini G, Facchinetti F, Baldoli E, Moro M, Casalini P, Caserini R, Milione M, Leone G, Pelosi G, Pastorino U, Sozzi G, Roz L.

Mol Oncol. 2016 Feb;10(2):253-71. doi: 10.1016/j.molonc.2015.10.002. Epub 2015 Oct 22.

34.

Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR.

Conte D, Verri C, Borzi C, Suatoni P, Pastorino U, Sozzi G, Fortunato O.

BMC Genomics. 2015 Oct 23;16:849. doi: 10.1186/s12864-015-2097-9.

35.

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.

Sestini S, Boeri M, Marchiano A, Pelosi G, Galeone C, Verri C, Suatoni P, Sverzellati N, La Vecchia C, Sozzi G, Pastorino U.

Oncotarget. 2015 Oct 20;6(32):32868-77. doi: 10.18632/oncotarget.5210.

36.

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations.

Hu J, Boeri M, Sozzi G, Liu D, Marchianò A, Roz L, Pelosi G, Gatter K, Pastorino U, Pezzella F.

EBioMedicine. 2015 Jul 8;2(8):831-40. doi: 10.1016/j.ebiom.2015.07.001. eCollection 2015 Aug.

37.

Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.

Bertolini G, D'Amico L, Moro M, Landoni E, Perego P, Miceli R, Gatti L, Andriani F, Wong D, Caserini R, Tortoreto M, Milione M, Ferracini R, Mariani L, Pastorino U, Roato I, Sozzi G, Roz L.

Cancer Res. 2015 Sep 1;75(17):3636-49. doi: 10.1158/0008-5472.CAN-14-3781. Epub 2015 Jul 3.

38.
39.

Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.

Boeri M, Sestini S, Fortunato O, Verri C, Suatoni P, Pastorino U, Sozzi G.

Expert Rev Mol Diagn. 2015 Jun;15(6):801-13. doi: 10.1586/14737159.2015.1041377. Epub 2015 Apr 30. Review.

PMID:
25924864
40.

Alkali-templated surface nanopatterning of chalcogenide thin films: a novel approach toward solar cells with enhanced efficiency.

Reinhard P, Bissig B, Pianezzi F, Hagendorfer H, Sozzi G, Menozzi R, Gretener C, Nishiwaki S, Buecheler S, Tiwari AN.

Nano Lett. 2015 May 13;15(5):3334-40. doi: 10.1021/acs.nanolett.5b00584. Epub 2015 Apr 8.

PMID:
25844923
41.

Potential biomarkers for lung cancer screening.

Sozzi G, Boeri M.

Transl Lung Cancer Res. 2014 Jun;3(3):139-48. doi: 10.3978/j.issn.2218-6751.2014.06.04. Review.

42.

A Japanese plum α-l-arabinofuranosidase/β-D-xylosidase gene is developmentally regulated by alternative splicing.

Di Santo MC, Ilina N, Pagano EA, Sozzi GO.

Plant Sci. 2015 Feb;231:173-83. doi: 10.1016/j.plantsci.2014.12.001. Epub 2014 Dec 5.

PMID:
25576002
43.

Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.

Dall'Asta A, Gizzo S, Musarò A, Quaranta M, Noventa M, Migliavacca C, Sozzi G, Monica M, Mautone D, Berretta R.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):8136-42. eCollection 2014.

44.

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.

Fortunato O, Boeri M, Moro M, Verri C, Mensah M, Conte D, Caleca L, Roz L, Pastorino U, Sozzi G.

Cell Death Dis. 2014 Dec 11;5:e1564. doi: 10.1038/cddis.2014.507.

45.

Therapeutic use of microRNAs in lung cancer.

Fortunato O, Boeri M, Verri C, Moro M, Sozzi G.

Biomed Res Int. 2014;2014:756975. doi: 10.1155/2014/756975. Epub 2014 Sep 16. Review.

46.

Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.

Milione M, Gasparini P, Sozzi G, Mazzaferro V, Ferrari A, Casali PG, Perrone F, Tamborini E, Pellegrinelli A, Gherardi G, Arrigoni G, Collini P, Testi A, De Paoli E, Aiello A, Pilotti S, Pelosi G.

Histopathology. 2014 Jun;64(7):1014-26. doi: 10.1111/his.12350. Epub 2014 Feb 25.

PMID:
24898918
47.

YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.

Lorenzetto E, Brenca M, Boeri M, Verri C, Piccinin E, Gasparini P, Facchinetti F, Rossi S, Salvatore G, Massimino M, Sozzi G, Maestro R, Modena P.

Oncotarget. 2014 May 15;5(9):2608-21.

48.

Assessment of circulating microRNAs in plasma of lung cancer patients.

Fortunato O, Boeri M, Verri C, Conte D, Mensah M, Suatoni P, Pastorino U, Sozzi G.

Molecules. 2014 Mar 10;19(3):3038-54. doi: 10.3390/molecules19033038.

49.

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, Marchiano A, Negri E, La Vecchia C, Pastorino U.

J Clin Oncol. 2014 Mar 10;32(8):768-73. doi: 10.1200/JCO.2013.50.4357. Epub 2014 Jan 13. Erratum in: J Clin Oncol. 2014 May 10;32(14):1520.

50.

Molecular sputum analysis for the diagnosis of lung cancer.

Hubers AJ, Prinsen CF, Sozzi G, Witte BI, Thunnissen E.

Br J Cancer. 2013 Aug 6;109(3):530-7. doi: 10.1038/bjc.2013.393. Epub 2013 Jul 18. Review.

Supplemental Content

Support Center